SCHEMBL20196091

SCHEMBL20196091

CCSc1c(Cl)cc(Cl)cc1CN

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.38
CYP2C9 P11712 2/20 0.38
IDO1 P14902 5/20 0.35
MAPK1 P28482 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
PRMT1 Q99873 1/20 0.33
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15358153 0.84 SCN4A (0.33) CYP1A2CYP2C9CYP3A4CYP2A6AOC3
SCHEMBL20196350 0.81 CYP1A2 (0.34) CYP1A2CYP2C9IDO1MAPK1ALDH1A1
SCHEMBL15358120 0.80 ALDH1A1 (0.37) ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL20196059 0.75 GRIN2D (0.38) CYP1A2CYP2C9MAPK1ALDH1A1CYP3A4
SCHEMBL16676160 0.73 SMN1; SMN2 (0.33) IDO1MAPK1ALDH1A1NPC1HPGD
Trifluoroacetic Acid SCHEMBL16528638 0.72 F2 (0.35) ALDH1A1CYP3A4
SCHEMBL1196194 0.72 DDR1 (0.40) CYP1A2CYP2C9IDO1MAPK1CYP3A4
Hydrochloric Acid SCHEMBL1016081 0.70 AOC3 (0.42) CYP1A2CYP2C9IDO1CYP3A4CYP2C19
SCHEMBL1764819 0.69 ALDH1A1 (0.52) CYP1A2CYP2C9IDO1ALDH1A1CYP3A4
SCHEMBL30812547 0.67 ALDH1A1 (0.40) CYP1A2CYP2C9IDO1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005739-B2 Quinazolinone and isoquinolinone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2018-06-26 US disclosed
EP-2842939-B1 BENZAMIDE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2018-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10005739-B2 Quinazolinone and isoquinolinone derivative NQO2, SDHA, CYP3A5 CYP1A2 59/4885CYP2C9 77/4885IDO1 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.